Atinary Technologies and Snapdragon Chemistry have begun collaborating to build a fully automated, AI-driven solid-phase oligonucleotide synthesiser (SPOS).
The medium-throughput technology will primarily support the optimisation of oligonucleotide synthesis.
As part of the collaboration, Snapdragon will integrate its LabOS software platform with Atinary's AI platform, SDLabs technology.
In test applications, the combination has been proven to demonstrate significant improvements, with an 18% increase in product yield already observed.
As well as this, the SPOS offers a 22% cost reduction compared with processes optimised by an experienced scientist, according to the duo.
CEO and co-founder of Atinary Technologies, Dr Hermann Tribukait, commented: “Atinary is committed to accelerating innovation and delivering cutting-edge solutions to our customers,”
“Our work with Snapdragon showcases the power of our AI and data-driven process to solve complex chemistry and molecular discovery challenges in the pharmaceutical and biotech industry, orders of magnitude faster than traditional methods.”
Snapdragon’s state-of-the-art laboratories and process development capabilities, along with their ability to design and build self-contained reactors, will be instrumental in this collaboration.
“We are excited about the opportunity to expand Snapdragon’s technological capability by integrating Atinary’s AI technology in our process R&D activities,” said Dr Eric Fang, General Manager of Snapdragon Chemistry.
“We believe that our combined expertise and shared vision for accelerated innovation will lead to significant advancements and added value for our customers, streamlining and expediting drug development pipelines and R&D portfolios.”
